Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications

Glioma is one of the most aggressive types of primary brain tumor with a high-grade glioma known as glioblastoma multiforme (GBM). Patients diagnosed with GBM usually have an overall survival rate of less than 18 months after conventional therapy. This bleak prognosis underlines the need to consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Suprava, Dash, Banendu Sunder, Premji, Thejas P., Chen, Jyh-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341481/
https://www.ncbi.nlm.nih.gov/pubmed/37445721
http://dx.doi.org/10.3390/ijms241310546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341481/
https://www.ncbi.nlm.nih.gov/pubmed/37445721
http://dx.doi.org/10.3390/ijms241310546

Ejemplares similares